OSMCX | RAIIX | OSMCX / RAIIX | |
Total Expense Ratio | 2.13 | 1.16 | 184% |
Annual Report Gross Expense Ratio | 2.13 | 1.16 | 184% |
Fund Existence | 28 years | 14 years | - |
Gain YTD | 15.235 | 24.629 | 62% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.5B | 390M | 898% |
Annual Yield % from dividends | 0.47 | 0.11 | 436% |
Returns for 1 year | -4.51 | 19.28 | -23% |
Returns for 3 years | 17.62 | 43.24 | 41% |
Returns for 5 years | -26.82 | 5.19 | -517% |
Returns for 10 years | 5.39 | 82.61 | 7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
FBAFX | 39.01 | 0.04 | +0.10% |
American Funds American Balanced 529-F-2 | |||
SCOBX | 46.28 | -0.03 | -0.06% |
DWS International Growth S | |||
TAIWX | 13.94 | -0.09 | -0.64% |
Nuveen Quant Intl Small Cap Eq W |